← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novavax, Inc.
Rockville, MD
$2,161,987
Total funding
4
Grants
Funding over time
peak $509.6K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,161,987 · 4
By mechanism
U01$1,040,921 · 1
UC1$848,254 · 1
R43$246,812 · 1
RC1$26,000 · 1
Investigators at Novavax, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Production of Non-Egg grown Influenza Vaccines$848,254
UC1 · FY2000 · AI
Development of Recombinant SARS VLP Vaccines$509,590
U01 · FY2007 · AI
Development of Recombinant SARS VLP Vaccines$270,605
U01 · FY2006 · AI
Development of Recombinant SARS VLP Vaccines$260,726
U01 · FY2005 · AI
Development of a Virus-like Particle (VLP) Vaccine for RSV$246,812
R43 · FY2009 · AI
PRODUCTION OF NON-EGG GROWN INFLUENZA VACCINES$26,000
RC1 · FY2000 · AI